CS1:LSE:LSE-Amundi IBEX 35 UCITS ETF Acc GBP (GBX)

ETF | Others |

Last Closing

USD 27777.5

Change

-122.50 (-0.44)%

Market Cap

USD 0.11B

Volume

1.04K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R1O:LSE Amazon.com Inc.

+4.05 (+2.20%)

USD 1,607.29B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.06 (+0.46%)

USD 640.06B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.12 (+0.65%)

USD 640.06B
0R1I:LSE NVIDIA Corp.

+2.98 (+2.82%)

USD 618.20B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

-1.80 (-2.46%)

USD 266.08B
PRJU:LSE Amundi Index Solutions - Amund..

+0.13 (+0.43%)

USD 259.48B
0QZO:LSE 0QZO

N/A

USD 258.54B
0QZ3:LSE Qualcomm Inc.

+1.00 (+0.69%)

USD 202.26B
0R24:LSE Intel Corp.

-1.08 (-5.12%)

USD 196.14B

ETFs Containing CS1:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.19% 95% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 18.19% 95% A 91% A-
Trailing 12 Months  
Capital Gain 24.56% 94% A 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 24.56% 93% A 87% B+
Trailing 5 Years  
Capital Gain 128.58% 92% A 91% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 128.58% 92% A 90% A-
Average Annual (5 Year Horizon)  
Capital Gain 14.15% 79% B- 78% C+
Dividend Return 14.15% 78% C+ 78% C+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.87% 56% F 74% C
Risk Adjusted Return 119.17% 97% N/A 98% N/A
Market Capitalization 0.11B 51% F 29% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike